Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04352309
What this trial is testing

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Post-approval studies (Phase 4)Study completedNCT01591460
What this trial is testing

A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 165
Testing effectiveness (Phase 2)Study completedNCT01353248
What this trial is testing

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 141
Testing effectiveness (Phase 2)Study completedNCT02993250
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 33
Testing effectiveness (Phase 2)UnknownNCT00563173
What this trial is testing

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C Virus Infection
Tripep AB 12
Testing effectiveness (Phase 2)Study completedNCT01260350
What this trial is testing

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 292
Post-approval studies (Phase 4)Ended earlyNCT00493805
What this trial is testing

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

Who this might be right for
Hepatitis C, ChronicInsulin Resistance
Merck Sharp & Dohme LLC 59
Early research (Phase 1)Study completedNCT01144936
What this trial is testing

Study of VX-985 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 21
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Post-approval studies (Phase 4)Study completedNCT00152581
What this trial is testing

Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

Who this might be right for
Chronic Hepatitis C, HCV Genotype 1
University College London Hospitals 40
Testing effectiveness (Phase 2)Study completedNCT00556504
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp. 84
Large-scale testing (Phase 3)Study completedNCT01330316
What this trial is testing

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

Who this might be right for
Hepatitis C
Boehringer Ingelheim 119
Post-approval studies (Phase 4)Study completedNCT00495131
What this trial is testing

Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients

Who this might be right for
Hepatitis C, Chronic
National Taiwan University Hospital 308
Large-scale testing (Phase 3)Ended earlyNCT00296972
What this trial is testing

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Who this might be right for
Chronic Hepatitis CHIV Infections
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Study completedNCT00926120
What this trial is testing

The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC

Who this might be right for
Hepatitis C
Brooke Army Medical Center 10
Large-scale testing (Phase 3)Study completedNCT03362814
What this trial is testing

Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.

Who this might be right for
HCV
Ascletis Pharmaceuticals Co., Ltd. 425
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Large-scale testing (Phase 3)Study completedNCT04155515
What this trial is testing

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 370
Large-scale testing (Phase 3)Study completedNCT00627926
What this trial is testing

Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 1,095
Testing effectiveness (Phase 2)Study completedNCT01464827
What this trial is testing

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1
AbbVie (prior sponsor, Abbott) 580
Next Page